Delivery Order SPE2DB22D3011-SPE2DB24FP8VJ
- Not listed
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,563,667,002 units of 20 mg Vyvanse capsules, with a potential value of $2,705.14 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not have a set-aside designation. This award is...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of 100 units of the pharmaceutical drug Vyvanse (40 mg capsules). The total potential value of this order is $1,012.50, with a completion date of February 23, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,787,389 units of 40 mg Vyvanse capsules. The contract has a potential value of $2,038.25 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under a larger indefinite...
- This is a firm fixed price delivery order worth $1,158.09 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of 100 units of the 50 mg capsule form of the prescription drug Vyvanse, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp is an...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,729.58 award is for the provision of 100 units of the 40 milligram strength capsule form of the prescription medication Vyvanse. This delivery order does not utilize any set-aside designations. Amerisourcebergen Drug Corp is also the prime contractor on a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 40mg Vyvanse capsules. The contract has a potential value of $36,017.18 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is the sole awardee on this delivery order, which is not associated with any set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $37,788.67, is for the supply of 40 milligram capsules of the pharmaceutical product Vyvanse. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 10 milligram Vyvanse capsules, a specialty medication, valued at $5,133.04 with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,282,910 units of Vyvanse 40 mg capsules. The total potential value of the award is $2,187.60, with a completion date of January 10, 2024. This delivery order is part of Amerisourcebergen's broader indefinite delivery contract with the DLA to provide pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,756,004 units of the prescription medication Vyvanse 30 mg capsules. The total potential value of the award is $1,997.00 with a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this contract. This...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP8VJDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the supply of Vyvanse 60 mg capsules, a pharmaceutical product, with a potential value of $1,813.49 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not set aside for any particular business type. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/26/24 |